To identify the molecular mechanisms that underlie the induced apoptosis in glioma cells treated with hUCBSC and siXIAP, we focused on the Bcl-2 family of apoptosis regulators that integrate cellular survival and apoptotic signals through their action on mitochondria. The gene discussed is BCL2; the disease is central nervous system cancer.